Viewing Study NCT04911556


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2025-12-30 @ 3:44 AM
Study NCT ID: NCT04911556
Status: UNKNOWN
Last Update Posted: 2021-06-03
First Post: 2021-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: the Effect of Probiotics on Aging Population
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D000073496', 'term': 'Frailty'}], 'ancestors': [{'id': 'D010335', 'term': 'Pathologic Processes'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR'], 'maskingDescription': 'Participant ,care provider,investigator and outcomes Assessor are all blind.'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'One group served as a control group, while the other three groups are treated with different strains of bifidobacterium longum'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 120}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'NOT_YET_RECRUITING', 'startDateStruct': {'date': '2021-06-01', 'type': 'ESTIMATED'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2021-05', 'completionDateStruct': {'date': '2022-12-31', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2021-06-02', 'studyFirstSubmitDate': '2021-05-12', 'studyFirstSubmitQcDate': '2021-06-02', 'lastUpdatePostDateStruct': {'date': '2021-06-03', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2021-06-03', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2022-06-30', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Points of probiotics intervention in aging population', 'timeFrame': 'one year', 'description': 'The score of Frail scale 0 points is defined as normal.And 1 to 3 points is defined as the early age of debility.Three points or more is defined as debility.The score is lower than before, meaning probiotic intervention can alleviate debility.'}]}, 'oversightModule': {'oversightHasDmc': True, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['intestinal flora'], 'conditions': ['Debility']}, 'descriptionModule': {'briefSummary': 'This study intends to recruit aging population (over 65 years old). The investigators use 16 SrDNA sequencing technology, genome sequencing technology, metabonomics, random forest forecast model, analysing and selecting specific age-related intestinal flora. The investigators select probiotics slowing down senility. Then the investigators use the probiotics to intervene in the aging population. Finally the investigators observe whether the probiotics can delay aging.', 'detailedDescription': 'This project plans to recruit the aging population (aged over 65 years old) and comprehensively analyze the public database and self-sequencing clinical big data by using 16 srDNA sequencing technology, metagenomic sequencing technology, metabonomics methods and Random Forest (R) prediction model to judge the key bacterial communities and related functional pathways related to aging.Based on the analysis results, the probiotics with the potential to alleviate aging were selected for intervention evaluation of aging population. This topic aims to explore the change process of intestinal flora structure and composition related to aging process.Identify the key intestinal bacteria genera/species/strains associated with aging, and target the pathway and metabolic characteristic spectrum of the key bacterial communities associated with aging;And select and breed specific intestinal bacterial strains related to aging.The aim is to reduce the age-related metabolic abnormalities and chronic inflammation, reduce medical treatment, rationally allocate medical resources, reduce medical costs and improve the quality of life.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['OLDER_ADULT'], 'minimumAge': '65 Years', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n1. Over 65 years old\n2. Frail scale score above 3 points\n\nExclusion Criteria:\n\n1. Severe impairment of liver and kidney function\n2. The tumor is advanced and life expectancy is less than 2 years\n3. Severe cognitive impairment and inability to cooperate\n4. Unable to give informed consent\n5. Have participated in other study before'}, 'identificationModule': {'nctId': 'NCT04911556', 'acronym': 'TEOPOGP', 'briefTitle': 'the Effect of Probiotics on Aging Population', 'organization': {'class': 'OTHER', 'fullName': "Wuxi People's Hospital"}, 'officialTitle': 'Study for the Effect of Probiotics on Aging Population', 'orgStudyIdInfo': {'id': 'Z202002'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'PLACEBO_COMPARATOR', 'label': 'the placebo group', 'description': 'A placebo made of starch', 'interventionNames': ['Dietary Supplement: A placebo made of starch']}, {'type': 'EXPERIMENTAL', 'label': 'Bifidobacterium longum group 1', 'description': 'Bifidobacterium longum 274', 'interventionNames': ['Dietary Supplement: Bifidobacterium longum']}, {'type': 'EXPERIMENTAL', 'label': 'Bifidobacterium longum group 2', 'description': 'Bifidobacterium longum 4-1', 'interventionNames': ['Dietary Supplement: Bifidobacterium longum']}, {'type': 'EXPERIMENTAL', 'label': 'Bifidobacterium longum group 3', 'description': 'Bifidobacterium longum gs', 'interventionNames': ['Dietary Supplement: Bifidobacterium longum']}], 'interventions': [{'name': 'Bifidobacterium longum', 'type': 'DIETARY_SUPPLEMENT', 'description': 'types of intestinal flora', 'armGroupLabels': ['Bifidobacterium longum group 1', 'Bifidobacterium longum group 2', 'Bifidobacterium longum group 3']}, {'name': 'A placebo made of starch', 'type': 'DIETARY_SUPPLEMENT', 'description': 'placebo', 'armGroupLabels': ['the placebo group']}]}, 'contactsLocationsModule': {'centralContacts': [{'name': 'Kan Hong, doctor', 'role': 'CONTACT', 'email': '2898456291@qq.com', 'phone': '13358119885'}], 'overallOfficials': [{'name': 'Kan Hong, doctor', 'role': 'STUDY_DIRECTOR', 'affiliation': "Wuxi People's hospitial"}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': "Wuxi People's Hospital", 'class': 'OTHER'}, 'collaborators': [{'name': 'Jiangnan University', 'class': 'OTHER'}], 'responsibleParty': {'type': 'SPONSOR'}}}}